Cormorant Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4M | Sell |
2,086,600
-175,000
| -8% | -$2.3M | 2.04% | 15 |
|
|
2025
Q1 | $32.5M | Sell |
2,261,600
-300,000
| -12% | -$4.31M | 2.45% | 12 |
|
|
2024
Q4 | $42.9M | Hold |
2,561,600
| – | – | 2.36% | 12 |
|
|
2024
Q3 | $41M | Buy |
2,561,600
+950,000
| +59% | +$15.2M | 2.17% | 15 |
|
|
2024
Q2 | $14.6M | Buy |
1,611,600
+1,050,000
| +187% | +$9.48M | 0.84% | 32 |
|
|
2024
Q1 | $6.35M | Hold |
561,600
| – | – | 0.28% | 49 |
|
|
2023
Q4 | $4.47M | Hold |
561,600
| – | – | 0.21% | 42 |
|
|
2023
Q3 | $3.63M | Hold |
561,600
| – | – | 0.21% | 41 |
|
|
2023
Q2 | $3.48M | Hold |
561,600
| – | – | 0.19% | 51 |
|
|
2023
Q1 | $2.16M | Hold |
561,600
| – | – | 0.14% | 59 |
|
|
2022
Q4 | $1.74M | Sell |
561,600
-1,411,128
| -72% | -$4.37M | 0.12% | 60 |
|
|
2022
Q3 | $7.93M | Sell |
1,972,728
-954,545
| -33% | -$3.84M | 0.55% | 43 |
|
|
2022
Q2 | $14.3M | Buy |
2,927,273
+437,379
| +18% | +$2.13M | 1.08% | 31 |
|
|
2022
Q1 | $22.3M | Hold |
2,489,894
| – | – | 1.71% | 17 |
|
|
2021
Q4 | $28M | Buy |
2,489,894
+762,621
| +44% | +$8.59M | 1.67% | 20 |
|
|
2021
Q3 | $28.7M | Buy |
1,727,273
+300,000
| +21% | +$4.99M | 1.17% | 27 |
|
|
2021
Q2 | $31.1M | Buy |
+1,427,273
| New | +$31.1M | 1.05% | 25 |
|